Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Ciprofloxacin in Mild to Moderate Skin Infections
NCT00257036Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 1991
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in skin and skin structure infections (SSSIs) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Clinical response to treatment, Microbiological response at post-therapy and 1 more. Started Jul 1991; status: completed.
02
Drugs
levofloxacin
03
Conditions
skin and skin structure infections (SSSIs)
Beyond the preview
Go deeper on NCT00257036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257036.